Perkes IE, Menon DK, Nott MT, Baguley IJ. Paroxysmal sympathetic hyperactivity after acquired brain injury: a review of diagnostic criteria. Brain Inj. 2011;25:925–32.
Baguley IJ, Perkes IE, Fernandez-Ortega JF, Rabinstein AA, Dolce G, Hendricks HT, et al. Paroxysmal sympathetic hyperactivity after acquired brain injury: consensus on conceptual definition, nomenclature, and diagnostic criteria. J Neurotrauma. 2014;31:1515–20.
Fernandez-Ortega JF, Baguley IJ, Gates TA, Garcia-Caballero M, Quesada-Garcia JG, Prieto-Palomino MA. Catecholamines and Paroxysmal Sympathetic Hyperactivity after Traumatic Brain Injury. J Neurotrauma. 2017;34:109–14.
Hinson HE, Puybasset L, Weiss N, Perlbarg V, Benali H, Galanaud D, et al. Neuroanatomical basis of paroxysmal sympathetic hyperactivity: a diffusion tensor imaging analysis. Brain Inj. 2015;29:455–61.
Article PubMed PubMed Central Google Scholar
Meyfroidt G, Baguley IJ, Menon DK. Paroxysmal sympathetic hyperactivity: the storm after acute brain injury. Lancet Neurol. 2017;16:721–9.
Jafari AA, Shah M, Mirmoeeni S, Hassani MS, Nazari S, Fielder T, et al. Paroxysmal sympathetic hyperactivity during traumatic brain injury. Clin Neurol Neurosurg. 2022;212:107081.
Louraoui SM, Fliyou F, Aasfara J, El Azhari A. Paroxysmal Sympathetic Hyperactivity After Traumatic Brain Injury: What Is Important to Know? Cureus. 2022;14:e24693.
PubMed PubMed Central Google Scholar
Khalid F, Yang GL, McGuire JL, Robson MJ, Foreman B, Ngwenya LB, et al. Autonomic dysfunction following traumatic brain injury: translational insights. Neurosurg Focus. 2019;47:E8.
Dias C, Gaio AR, Monteiro E, Barbosa S, Cerejo A, Donnelly J, et al. Kidney-brain link in traumatic brain injury patients? A preliminary report. Neurocrit Care. 2015;22:192–201.
Fernandez-Ortega JF, Prieto-Palomino MA, Munoz-Lopez A, Lebron-Gallardo M, Cabrera-Ortiz H, Quesada-Garcia G. Prognostic influence and computed tomography findings in dysautonomic crises after traumatic brain injury. J Trauma. 2006;61:1129–33.
Lv LQ, Hou LJ, Yu MK, Qi XQ, Chen HR, Chen JX, et al. Prognostic influence and magnetic resonance imaging findings in paroxysmal sympathetic hyperactivity after severe traumatic brain injury. J Neurotrauma. 2010;27:1945–50.
Nott MT, Chapparo C, Baguley IJ. Agitation following traumatic brain injury: an Australian sample. Brain Inj. 2006;20:1175–82.
Baguley IJ, Nott MT, Slewa-Younan S, Heriseanu RE, Perkes IE. Diagnosing dysautonomia after acute traumatic brain injury: evidence for overresponsiveness to afferent stimuli. Arch Phys Med Rehabil. 2009;90:580–6.
Samuel S, Lee M, Brown RJ, Choi HA, Baguley IJ. Incidence of paroxysmal sympathetic hyperactivity following traumatic brain injury using assessment tools. Brain Inj. 2018;32:1115–21.
Mathew MJ, Deepika A, Shukla D, Devi BI, Ramesh VJ. Paroxysmal sympathetic hyperactivity in severe traumatic brain injury. Acta Neurochir. 2016;158:2047–52.
Ammar MA, Hussein NS. Using propranolol in traumatic brain injury to reduce sympathetic storm phenomenon: A prospective randomized clinical trial. Saudi J Anaesth. 2018;12:514–20.
Article PubMed PubMed Central Google Scholar
Jang SH, Kwon HG. Injury of the Hypothalamus in Patients With Hypoxic-Ischemic Brain Injury: A Diffusion Tensor Imaging Study. Am J Phys Med Rehabil. 2018;97:160–3.
Zhao ZD, Yang WZ, Gao C, Fu X, Zhang W, Zhou Q, et al. A hypothalamic circuit that controls body temperature. Proc Natl Acad Sci USA. 2017;114:2042–7.
Article ADS CAS PubMed PubMed Central Google Scholar
Lee SJ, Jang SH. Hypothalamic injury in spontaneous subarachnoid hemorrhage: a diffusion tensor imaging study. Clin Auton Res. 2021;31:321–2.
Jang SH, Yi JH, Kim SH, Kwon HG. Relation between injury of the hypothalamus and subjective excessive daytime sleepiness in patients with mild traumatic brain injury. J Neurol Neurosurg Psychiatry. 2016;87:1260–1.
Jang SH, Seo YS. Neurogenic fever due to injury of the hypothalamus in a stroke patient: Case report. Medicine. 2021;100:e24053.
Article PubMed PubMed Central Google Scholar
Jang SH, Choi KH. Paroxysmal sympathetic hyperactivity concurrent with hypothalamic injury in a patient with intracerebral hemorrhage: A case report. Medicine. 2022;101:e30058.
Article PubMed PubMed Central Google Scholar
Ding JS, Zhang Y, Wang TY, Li X, Ma C, Xu ZM, et al. Therapeutic applications of hydrogen sulfide and novel donors for cerebral ischemic stroke: a narrative review. Med Gas Res. 2023;13:7–9.
Article CAS PubMed Google Scholar
Fan J, Du J, Zhang Z, Shi W, Hu B, Hu J, et al. The Protective Effects of Hydrogen Sulfide New Donor Methyl S-(4-Fluorobenzyl)-N-(3,4,5-Trimethoxybenzoyl)-l-Cysteinate on the Ischemic Stroke. Molecules. 2022;27:1554.
Article CAS PubMed PubMed Central Google Scholar
Pomierny B, Krzyzanowska W, Jurczyk J, Skorkowska A, Strach B, Szafarz M, et al. The Slow-Releasing and Mitochondria-Targeted Hydrogen Sulfide (H(2)S) Delivery Molecule AP39 Induces Brain Tolerance to Ischemia. Int J Mol Sci. 2021;22:7816.
Article CAS PubMed PubMed Central Google Scholar
Yu Q, Guo Q, Jin S, Gao C, Zheng P, Li DP, et al. Melatonin suppresses sympathetic vasomotor tone through enhancing GABA(A) receptor activity in the hypothalamus. Front Physiol. 2023;14:1166246.
Article PubMed PubMed Central Google Scholar
Messmer SJ, Salmeron KE, Frank JA, McLouth CJ, Lukins DE, Hammond TC, et al. Extended Middle Cerebral Artery Occlusion (MCAO) Model to Mirror Stroke Patients Undergoing Thrombectomy. Transl Stroke Res. 2022;13:604–15.
Article CAS PubMed Google Scholar
Zhang Q, Yin J, Xu F, Zhai J, Yin J, Ge M, et al. Isoflurane post-conditioning contributes to anti-apoptotic effect after cerebral ischaemia in rats through the ERK5/MEF2D signaling pathway. J Cell Mol Med. 2021;25:3803–15.
Article CAS PubMed PubMed Central Google Scholar
Chen Z, Zhang Y, Wu X, Huang H, Chen W, Su Y. Characteristics and Outcomes of Paroxysmal Sympathetic Hyperactivity in Anti-NMDAR Encephalitis. Front Immunol. 2022;13:858450.
Article CAS PubMed PubMed Central Google Scholar
Feng S, Chen JX, Liu S, Zheng P, Sun J, Zhang X, et al. Clinical and prognostic study of anti-N-methyl-D-aspartate receptor encephalitis children with paroxysmal sympathetic hyperactivity syndrome. Zhonghua Yi Xue Za Zhi. 2021;101:3600–3..
Xu L, Qiu X, Wang S, Wang Q, Zhao XL. NMDA Receptor Antagonist MK801 Protects Against 1-Bromopropane-Induced Cognitive Dysfunction. Neurosci Bull. 2019;35:347–61.
Lipton SA, Choi YB, Takahashi H, Zhang D, Li W, Godzik A, et al. Cysteine regulation of protein function-as exemplified by NMDA-receptor modulation. Trends Neurosci. 2002;25:474–80.
Article CAS PubMed Google Scholar
Siefferman JW, Lai G. Propranolol for Paroxysmal Sympathetic Hyperactivity with Lateralizing Hyperhidrosis after Stroke. Case Rep Neurol Med. 2015;2015:421563.
PubMed PubMed Central Google Scholar
Du Y, Demillard LJ, Ren J. Catecholamine-induced cardiotoxicity: A critical element in the pathophysiology of stroke-induced heart injury. Life Sci. 2021;287:120106.
Article CAS PubMed Google Scholar
Sternberg Z, Schaller B. Central Noradrenergic Agonists in the Treatment of Ischemic Stroke-an Overview. Transl Stroke Res. 2020;11:165–84.
Oto J, Suzue A, Inui D, Fukuta Y, Hosotsubo K, Torii M, et al. Plasma proinflammatory and anti-inflammatory cytokine and catecholamine concentrations as predictors of neurological outcome in acute stroke patients. J Anesth. 2008;22:207–12.
Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Gomez-Choco M, et al. Catecholamines, infection, and death in acute ischemic stroke. J Neurol Sci. 2007;252:29–35.
Article CAS PubMed Google Scholar
Strittmatter M, Meyer S, Fischer C, Georg T, Schmitz B. Location-dependent patterns in cardio-autonomic dysfunction in ischaemic stroke. Eur Neurol. 2003;50:30–8.
Article CAS PubMed Google Scholar
Huerta de la Cruz S, Rodriguez-Palma EJ, Santiago-Castaneda CL, Beltran-Ornelas JH, Sanchez-Lopez A, Rocha L, et al. Exogenous hydrogen sulfide restores CSE and CBS but no 3-MST protein expression in the hypothalamus and brainstem after severe traumatic brain injury. Metab Brain Dis. 2022;37:1863–74.
留言 (0)